Research Topics - Neurodegenerative Disease

Advancing Understanding of Neurological Disorders

Delve into ONEASA’s neurological research aimed at enhancing brain health and understanding neurological disorders across varied demographics.

Neurodegenerative Diseases

Neurodegenerative Diseases

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, pose a significant public health concern in Indonesia, as they do in many parts of the world. These complex and debilitating conditions, characterized by the progressive deterioration of the nervous system, present unique challenges in the Indonesian healthcare landscape. Estimates suggest that the prevalence of Alzheimer's disease, the most common form of dementia, is on the rise. However, a total of 86.3% of adults had not heard of the terms dementia or Alzheimer’s disease and commonly viewed dementia as a normal part of aging. 

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, pose a significant public health concern in Indonesia, as they do in many parts of the world. These complex and debilitating conditions, characterized by the progressive deterioration of the nervous system, present unique challenges in the Indonesian healthcare landscape. Estimates suggest that the prevalence of Alzheimer's disease, the most common form of dementia, is on the rise. However, a total of 86.3% of adults had not heard of the terms dementia or Alzheimer’s disease and commonly viewed dementia as a normal part of aging. 

In 2015, over 46 million people were living with dementia worldwide. Asia has the highest number of people with dementia compared to other regions. This number is estimated to increase to 131.5 million by 2050.

ASIA

22.9

22.MILLION

EUROPE

10.5

22.MILLION

AFRICA

4.0

22.MILLION

THE

AMERICAS

10.5

22.MILLION

Predicted by 2050, the number of dementia cases in Asia will be 2.7 times higher than in 2019

Prediction of People Living with Dementia in Indonesia

Indonesia was estimated to have 1.2 million people living with dementia in 2016 while it is expected to increase by 2.5 times in 2050 (Alzheimer’s Disease International (ADI)).


Our clinico-genomic research holds immense promise for addressing the growing burden of neurodegenerative diseases in Indonesia. By uncovering the unique genetic and molecular markers that influence the susceptibility, progression, and treatment response of these conditions, researchers can pave the way for personalized, targeted interventions that can significantly improve health outcomes and reduce the overall impact of neurodegenerative diseases on the Indonesian population.

Join the Journey towards Longevity with ONEASA

Discover sponsorship opportunities and join hands in unlocking longevity.

BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12,

Menteng, Central Jakarta, Indonesia 10350

© 2024 ONEASA. All rights reserved.

Join the Journey towards Longevity with ONEASA

Discover sponsorship opportunities and join hands in unlocking longevity.

Predicted by 2050, the number of dementia cases in Asia will be 2.7 times higher than in 2019

BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12,
Menteng, Central Jakarta, Indonesia 10350

© 2024 ONEASA. All rights reserved.

BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12,
Menteng, Central Jakarta, Indonesia 10350

© 2024 ONEASA. All rights reserved.

Indonesia was estimated to have 1.2 million people living with dementia in 2016 while it is expected to increase by 2.5 times in 2050.


Our clinico-genomic research holds immense promise for addressing the growing burden of neurodegenerative diseases in Indonesia. By uncovering the unique genetic and molecular markers that influence the susceptibility, progression, and treatment response of these conditions, researchers can pave the way for personalized, targeted interventions that can significantly improve health outcomes and reduce the overall impact of neurodegenerative diseases on the Indonesian population.

Prediction of People Living with Dementia in Indonesia

Join the Journey towards Longevity with ONEASA

Discover sponsorship opportunities and join hands in unlocking longevity.

BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12,

Menteng, Central Jakarta, Indonesia 10350

© 2024 ONEASA. All rights reserved.

BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12,

Menteng, Central Jakarta, Indonesia 10350

© 2024 ONEASA. All rights reserved.

Join the Journey towards Longevity with ONEASA

Discover sponsorship opportunities and join hands in unlocking longevity.

In 2015, over 46 million people were living with dementia worldwide. Asia has the highest number of people with dementia compared to other regions. This number is estimated to increase to 131.5 million by 2050.


ASIA

22.9

22.MILLION

EUROPE

10.5

22.MILLION

AFRICA

4.0

22.MILLION

THE

AMERICAS

10.5

22.MILLION

Neurodegenerative Diseases

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, pose a significant public health concern in Indonesia, as they do in many parts of the world. These complex and debilitating conditions, characterized by the progressive deterioration of the nervous system, present unique challenges in the Indonesian healthcare landscape. Estimates suggest that the prevalence of Alzheimer's disease, the most common form of dementia, is on the rise. However, a total of 86.3% of adults had not heard of the terms dementia or Alzheimer’s disease and commonly viewed dementia as a normal part of aging. 

Neurodegenerative Diseases

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, pose a significant public health concern in Indonesia, as they do in many parts of the world. These complex and debilitating conditions, characterized by the progressive deterioration of the nervous system, present unique challenges in the Indonesian healthcare landscape. Estimates suggest that the prevalence of Alzheimer's disease, the most common form of dementia, is on the rise. However, a total of 86.3% of adults had not heard of the terms dementia or Alzheimer’s disease and commonly viewed dementia as a normal part of aging. 

In 2015, over 46 million people were living with dementia worldwide. Asia has the highest number of people with dementia compared to other regions. This number is estimated to increase to 131.5 million by 2050.

ASIA

22.9

22.MILLION

EUROPE

10.5

22.MILLION

AFRICA

4.0

22.MILLION

THE

AMERICAS

10.5

22.MILLION

Predicted by 2050, the number of dementia cases in Asia will be 2.7 times higher than in 2019

Prediction of People Living with Dementia in Indonesia

Indonesia was estimated to have 1.2 million people living with dementia in 2016 while it is expected to increase by 2.5 times in 2050 (Alzheimer’s Disease International (ADI)).


Our clinico-genomic research holds immense promise for addressing the growing burden of neurodegenerative diseases in Indonesia. By uncovering the unique genetic and molecular markers that influence the susceptibility, progression, and treatment response of these conditions, researchers can pave the way for personalized, targeted interventions that can significantly improve health outcomes and reduce the overall impact of neurodegenerative diseases on the Indonesian population.

In 2015, over 46 million people were living with dementia worldwide. Asia has the highest number of people with dementia compared to other regions. This number is estimated to increase to 131.5 million by 2050.

Predicted by 2050, the number of dementia cases in Asia will be 2.7 times higher than in 2019

Prediction of People Living with Dementia in Indonesia

Indonesia was estimated to have 1.2 million people living with dementia in 2016 while it is expected to increase by 2.5 times in 2050 (Alzheimer’s Disease International (ADI)).


Estimated cost of treating people with dementia is about USD 2.2 billion each year.


Our clinico-genomic research holds immense promise for addressing the growing burden of neurodegenerative diseases in Indonesia. By uncovering the unique genetic and molecular markers that influence the susceptibility, progression, and treatment response of these conditions, researchers can pave the way for personalized, targeted interventions that can significantly improve health outcomes and reduce the overall impact of neurodegenerative diseases on the Indonesian population.

Research Topics - Neurodegenerative Disease

Advancing Understanding of Neurological Disorders

Delve into ONEASA’s neurological research aimed at enhancing brain health and understanding neurological disorders across varied demographics.

Research Topics - Neurodegenerative Disease

Advancing Understanding of Neurological Disorders

Delve into ONEASA’s neurological research aimed at enhancing brain health and understanding neurological disorders across varied demographics.

Research Topics - Neurodegenerative Disease

Advancing Understanding of Neurological Disorders

Delve into ONEASA’s neurological research aimed at enhancing brain health and understanding neurological disorders across varied demographics.

Research Topics - Neurodegenerative Disease

Advancing Understanding of Neurological Disorders

Delve into ONEASA’s neurological research aimed at enhancing brain health and understanding neurological disorders across varied demographics.

Research Topics - Neurodegenerative Disease

Advancing Understanding of Neurological Disorders

Delve into ONEASA’s neurological research aimed at enhancing brain health and understanding neurological disorders across varied demographics.

Research Topics - Neurodegenerative Disease

Advancing Understanding of Neurological Disorders

Delve into ONEASA’s neurological research aimed at enhancing brain health and understanding neurological disorders across varied demographics.

BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12,

Menteng, Central Jakarta, Indonesia 10350

© 2024 ONEASA. All rights reserved.

BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12,

Menteng, Central Jakarta, Indonesia 10350

© 2024 ONEASA. All rights reserved.